No interactions seen for any outcome; log-additive effect on risk of developing cardiovascular disease

Eversense CGM, which has fully implantable sensor to detect glucose, approved for adults with diabetes

Findings based on one-year follow-up in teens with type 1 diabetes participating in the STePS study

Patterns of use, timing of hospice similar among patients with diverse spending trajectories

Significantly lower annualized rates of documented symptomatic hypoglycemia than Gla-100

Better glycemic control than conventional subcutaneous insulin therapy in patients with T2DM

Increased risks of autism spectrum disorder in association with types 1, 2, gestational diabetes

In subgroup analyses, reduced incidence of cancer seen in participants aged younger than 65 years

Stigma is associated with two-fold higher odds of poor glycemic control after adjustment for confounders

Interviews show some quitters deliberately switch to e-cigs, while some use both